Bafna Pharmaceuticals obtains product approval from Ghana FDA

03 May 2013 Evaluate

Bafna Pharmaceuticals, a Chennai-based Pharma company, received approval from Ghana Food and Drug Administration (FDA) to market Omeran-20 capsules (Gastro - Resistant Omeprazole Capsules 20mg) , a proton pump inhibitor used in the treatment of reflux oesophagitis, peptic ulcer disease (PUD), Gastroesophageal reflux disease (GORD/GERD) and Zollinger-Ellison syndrome. With this, Bafna now has 15 number of formulation approvals from Ghana FDA for products of the company.

Bafna Pharmaceutical is a Chennai-based Pharma company engaged in the manufacturing of pharmaceutical formulations of Betalactum and Non-Betalactum.  The company has 173 products registered in UK, Sri Lanka, Nepal, Ukraine, Ghana, Ethiopia, Philippines, Kryghistan, Georgia, Honduras, Colombia, Uzbekhistan, Vietnam and Nigeria.

Bafna Pharma Share Price

122.50 4.20 (3.55%)
02-Feb-2026 09:02 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1609.35
Dr. Reddys Lab 1180.00
Cipla 1300.05
Zydus Lifesciences 865.20
Lupin 2089.70
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×